The investigators sought to examine the effects of 'old' red blood cells on mortality and morbidity of patients who undergoing revision hip replacement arthroplasty. The investigators hypothesis is that patients have an increased risk of mortality and infection after 'old' red blood cells transfusions compared with those who received 'new' transfusions.
Study Type
OBSERVATIONAL
Red blood cells (shelf life \> 14 days) transfusion during the operation (total hip replacement arthroplasty)
Red blood cells (shelf life =\< 14 days) transfusion during the operation (total hip replacement arthroplasty)
Seoul National University Bundang Hospital
Seongnam-si, South Korea
Mortality
Time frame: postoperative 7 days
Sepsis
Time frame: postoperative 7 days
Wound infection
Time frame: postoperative 7 days
Postoperative delirium
Time frame: postoperative 7 days
Postoperative bleeding
Time frame: postoperative 7 days
Transfusion related lung injury
Time frame: postoperative 7 days
Pulmonary edema
Time frame: postoperative 7 days
Pulmonary effusion
Time frame: postoperative 7 days
Myocardial ischemia
Time frame: postoperative 7 days
Pulmonary thromboembolism
Time frame: postoperative 7 days
Renal failure
Time frame: postoperative 7 days
Hepatic failure
Time frame: postoperative 7 days
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.